Research Articles

Efficacy of Sishen Wan (四神丸) on dinitrobenzene sulfonic acid-induced ulcerative colitis and its effect on toll-like receptor 2/interleukin-1 receptor-associated kinase-4/nuclear factor-κB signal pathway

  • Zhaohua ZHANG ,
  • Rong LIU ,
  • Nana DU ,
  • Xiangdong ZHU
Expand
  • 1 School of Basic Medicine, Gansu university of Chinese Medicine, Lanzhou 730000, China
    2 College of Chinese Medicine, Ningxia medical university, Yinchuan 750000, China
    3 Department of Thoracic Surgery, Gansu Provincial Cancer Hospital, Lanzhou 730000, China
Prof. ZHU Xiangdong, School of Basic Medicine, Gansu university of Chinese Medicine, Lanzhou 730000, China. zhuxiangdong33@163.com, Telephone: +86-15339312501

Received date: 2022-01-18

  Accepted date: 2022-04-15

  Online published: 2022-07-12

Supported by

Explore the Immune Mechanism of Treating Ulcerative Colitis by Regulating Treg/Th17 Cell Imbalance by Warming the Kidney and Invigorating the Spleen through Intestinal Flora(81960826)

Abstract

OBJECTIVE: To investigate the therapeutic effect of Sishen Wan (四神丸, SSW) on ulcerative colitis (UC) induced by dinitrobenzene sulfonic acid and its effect on toll-like receptor 2/interleukin-1 receptor-associated kinase-4/nuclear factor-κB (TLR2/IRAK4/NF-κB) sig-naling pathway in colonic tissue. METHODS: In this study, 120 Sprague-Dawley rats were randomly divided into blank and model groups. The experimental UC model in rats was established by subcutaneous injection of hydrocortisone + senna gavage for 21 d + dinitrobenzene sulfonic acid (DNBS)/ ethanol solution enema. The successful model rats were randomly divided into the model group; mesalazine (0.36 g/kg) group; and high-, medium-, and low- dose SSW (24, 12, and 6 g/kg) groups. The model and blank groups were gavaged with equal volumes of distilled water once a day for 21 d. The general condition of the rats was observed, and the body mass, fecal properties, and occult blood were recorded for calculating the disease activity index (DAI) score. The colonic tissue of the rats was collected, and its general morphology and pathological form were noted for obtaining the colonic mucosal injury index (CMDI) score. Hematoxylin-eosin staining was used to view the pathological changes of the colon tissue in each group, apoptosis of the cells was detected using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining, and quantitative real-time polymerase chain reaction was used to measure the expressions of TLR2, myeloid differentiation primary response gene 88 (MyD88), IRAK4, and NF-κB p65 mRNA in the colon tissue. The expressions of TLR2, MyD88, IRAK4, and NF-κB p65 protein were detected using western blotting and immunohistochemistry assay, and the levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the colon tissue were determined using enzyme linked immunosorbent assay. RESULTS: Compared with the blank group, the general condition of the model group was relatively poor. The DAI and CMDI scores of the model group increased significantly (P < 0.01), the glands and intestinal mucosa disappeared partially, and several inflammatory cells infiltrated and gathered in the mucosal layer and base layer of the rats in the model group. Furthermore, the cell apoptosis and expression levels of TLR2, MyD88, IRAK4, and NF-κB p65 mRNA and protein in the colon tissue of rats in the model group increased significantly (P < 0.01). The levels of IL-1β and TNF-α increased significantly in the colon tissue of rats in the model group (P < 0.01). After treatment with SSW, compared with the model group, the general condition of the UC rats improved. Moreover, the DAI and CMDI scores of the UC rats decreased significantly (P < 0.05), and the pathological changes in the colon tissue of the UC rats tended to be normal. The cell apoptosis and expression levels of TLR2, MyD88, IRAK4, and NF-κB p65 mRNA and protein in the colon tissue of the UC rats decreased gradually (P < 0.01), and the levels of IL-1β and TNF-α decreased significantly (P < 0.01). CONCLUSION: SSW can improve the general condition and alleviate the intestinal mucosal injury of UC model rats. Additionally, SSW can inhibit the TLR2/IRAK4/ NF-κB signaling pathway, but further studies are required to confirm it.

Cite this article

Zhaohua ZHANG , Rong LIU , Nana DU , Xiangdong ZHU . Efficacy of Sishen Wan (四神丸) on dinitrobenzene sulfonic acid-induced ulcerative colitis and its effect on toll-like receptor 2/interleukin-1 receptor-associated kinase-4/nuclear factor-κB signal pathway[J]. Journal of Traditional Chinese Medicine, 2022 , 42(4) : 565 -575 . DOI: 10.19852/j.cnki.jtcm.20220608.001

References

1 Eisenstein M. Ulcerative colitis: towards remission. Nature 2018; 563: S33.
2 Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Primers 2020; 6: 73.
3 Ungaro R, Mehandru S, Allen PB, et al Ulcerative colitis. Lancet 2017; 389: 1756-70.
4 Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc 2019; 94: 155-65.
5 Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am 2020; 49: 643-54.
6 Wehkamp J, Stange EF. Recent advances and emerging therapies in the non-surgical management of ulcerative colitis. F1000Res 2018; 7: F1000 Faculty Rev-1207.
7 Zheng L, Wen XL, Dai YC. Mechanism of Jianpi Qingchang Huashi Recipe in treating ulcerative colitis: A study based on network pharmacology and molecular docking. World J Clin Cases 2021; 9: 7653-70.
8 Chen W, He L, Zhong L, et al. Identification of active compounds and mechanism of Huangtu decoction for the treatment of ulcerative colitis by network pharmacology combined with experimental verification. Drug Des Devel Ther 2021; 15: 412540.
9 Zhang C, Zhu H, Jie H, et al. Arbutin ameliorated ulcerative colitis of mice induced by dextran sodium sulfate (DSS). Bioengineered 2021; 12: 11707-15.
10 Wang B, Liu Y, Sun J, et al. Exploring the potential mechanism of Xiaokui Jiedu Decoction for ulcerative colitis based on network pharmacology and molecular docking. J Healthc Eng 2021; 2021: 1536337.
11 Tan YY, Ding Y, Zheng X, et al. Ding's herbal enema treats dextran sulfate sodium-induced colitis in mice by regulating the gut microbiota and maintaining the Treg/Th17 cell balance. Exp Ther Med 2021, 22: 1368-79.
12 Ma JZ. Effect of Sishen Wan combined with Shenling Baizhu San on ulcerative colitis of spleen kidney Yang deficiency type. Hefei: Anhui University of Chinese Medicine, 2021: 12-56.
13 Cheng XH, Zhang QL, Gong XL, et al. Clinical study on Sishen Pills combined with mesalazine in treatment of ulcerative colitis. Xian Dai Yao Wu Yu Lin Chuang 2018; 33: 1085-8.
14 Xie H, Ming H. Sishen Pill combined with vesiculation cupping in the treatment of Yang deficiency of spleen and kidney diarrhoea for 30 Cases. Zhong Guo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu 2019; 17: 73-5.
15 Zhao HM, Liu Y, Huang XY, et al. Pharmacological mechanism of Sishen Wan(®) attenuated experimental chronic colitis by inhibiting wnt/β-catenin pathway. J Ethnopharmacol 2019; 240: 111936.
16 Wang HY, Zhao HM, Wang Y, et al. Sishen Wan(®) ameliorated trinitrobenzene-sulfonic-acid-induced chronic colitis via NEMO/NLK signaling pathway. Front Pharmacol 2019; 10: 170-80.
17 Wang G, Xu B, Shi F, et al. Protective effect of methane-rich saline on acetic acid-induced ulcerative colitis via blocking the TLR4/NF-κB/MAPK pathway and promoting IL-10/JAK1/STAT3-mediated anti-inflammatory response. Oxid Med Cell Longev 2019; 2019: 7850324.
18 Yang C, Guo X, Wang J, et al. Relationship between small intestinal bacterial overgrowth and peripheral blood ET, TLR2 and TLR4 in ulcerative colitis. J Coll Physicians Surg Pak 2020; 30: 245-9.
19 Zhang XX, Li XN, Hu S, et al. Simultaneous determination of nine bioactive components in Sishen Pills by HPLC-ESI-MS/MS. Zhong Cao Yao 2018; 49: 2070-5.
20 Zheng J, Cao ZB, Zhu Y. Discussion on establishment and evaluation of ulcerative colitis animal models with spleen-kidney yang deficiency pattern based on the theory of "combination of disease with syndrome". Zhong Guo Zhong Yi Yao Xin Xi Za Zhi 2016; 23: 16-8.
21 Wu YH, Xu YQ, Li HL, et al. Preparation of a rat model of ulcerative colitis with spleen and kidney Yang deficiency. Zhong Guo Shi Yan Dong Wu Xue Bao 2016; 24: 116-9.
22 Cheng XL, Zhu XD, Wang Y, et al. Effects of Sishen Wan on the contents of serum IL-23 and IL-27 and the expression of Foxp3 mRNA in colonic mucosa of rats with ulcerative colitis. Zhong Yi Yan Jiu 2016; 29: 66-70.
23 Totsuka T, Kanai T, Iiyama R, et al. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterol 2003; 124: 410-21.
24 Ke J, Bian X, Liu H, et al. Edaravone reduces oxidative stress and intestinal cell apoptosis after burn through up-regulating miR-320 expression. Mol Med 2019; 25: 54.
25 Liu D, Huang X, Cheng S, et al. Regulation of sishen wan on Bax/Bcl-2 mRNA, Fas/FasL in colonic tissue from rats with colitis. Zhong Guo Zhong Yao Za Zhi 2011; 36: 3484-8.
26 Wang Y, Liu R, Zhu XD. Immunohistochemical effect of sishen pill on PI3K /Akt/mTOR signal pathway in colonic tissue of rats with ulcerative colitis model of spleen kidney Yang deficiency. Zhong Guo Shi Yan Dong Wu Xue Bao 2021; 29: 42-8.
27 Liu R, Wang Y, Zhu XD, et al. Effect of Sishenwan on PI3K/Akt/mTOR signal pathway in colonic tissue of rats with ulcerative colitis model of spleen kidney Yang deficiency. Zhong Guo Shi Yan Fang Ji Xue Za Zhi 2021; 27: 16-23.
28 Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1: a001651.
29 Dolcet X, Llobet D, Pallares J, et al. NF-kB in development and progression of human cancer. Virchows Arch 2005; 446: 475-82.
30 Kunnumakkara AB, Shabnam B, Girisa S, et al. Inflammation, NF-κB, and chronic diseases: how are they linked? Crit Rev Immunol 2020; 40: 1-39.
31 Chen Y, Chen Y, Cao P, et al. Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF-κB via the upregulation of CARD3 expression. J Pathol 2020; 250: 170-82.
32 Gray CM, Remouchamps C, Mccorkell KA, et al. Noncanonical NF-κB signaling is limited by classical NF-κB activity. Sci Signal 2014; 7:ra13.
33 Liu AH, Wu YT, Wang YP. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway. Brain Res Bull 2017; 132: 139-49.
34 Torrealba N, Vera R, Fraile B, et al. TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer. Aging Male 2020; 23: 801-11.
35 Candia E, Díaz-Jiménez D, Langjahr P, et al. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology 2012; 217: 634-42.
36 Tan Y, Zou KF, Qian W, et al. Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis. Hua Zhong Ke Ji Da Xue Xue Bao Yi Xue Ban 2014; 34: 785-90.
37 Pennini ME, Perkins DJ, Salazar AM, et al. Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice. J Immunol 2013; 190: 307-16.
38 Padwal MK, Sarma U, Saha B. Comprehensive logic based analyses of toll-like receptor 4 signal transduction pathway. PLoS One 2014; 9: e92481.
39 Bahia MS, Kaur M, Silakari P, et al. Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders. Cell Signal 2015; 27: 1039-55.
Outlines

/